1. Brown KE. The expanding range of parvoviruses which infect humans. Rev Med Virol 2010;20(4):231-244.
2. Qiu J, Söderlund-Venermo M, Young NS. Human Parvoviruses. Clin Microbiol Rev 2017;30(1):43-113.
3. Söderlund-Venermo M. Emerging Human Parvoviruses: The Rocky Road to Fame. Annu Rev Virol 2019;6(1):71-91.
4. Landry ML. Parvovirus B19. Microbiol Spectr 2016;4(3):10.1128/microbiolspec.DMIH2-0008-2015.
5. Cotmore SF, Agbandje-McKenna M, Canuti M, et al. ICTV Virus Taxonomy Profile: Parvoviridae. J Gen Virol 2019;100(3):367-368.
6. Mietzsch M, Pénzes JJ, Agbandje-McKenna M. Twenty-Five Years of Structural Parvovirology. Viruses 2019;11(4):362.
7. Ganaie SS, Qiu J. Recent Advances in Replication and Infection of Human Parvovirus B19. Front Cell Infect Microbiol 2018;8:166.
8. Servant-Delmas A, Morinet F. Update of the human parvovirus B19 biology. Transfus Clin Biol 2016;23(1):5-12.
9. Parsyan A, Szmaragd C, Allain JP, Candotti D. Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol 2007;88(Pt 2):428-431.
10. Gigi CE, Anumba DOC. Parvovirus b19 infection in pregnancy – A review. Eur J Obstet Gynecol Reprod Biol 2021;264:358-362.
11. Gallinella G. The clinical use of parvovirus B19 assays: recent advances. Expert Rev Mol Diagn 2018;18(9):821-832.
12. Hübschen JM, Mihneva Z, Mentis AF, et al. Phylogenetic analysis of human parvovirus b19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests
the spread of genotype 3b. J Clin Microbiol 2009;47(11):3735-3738.
13. Norja P, Hokynar K, Aaltonen LM, et al. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A 2006;103(19):7450-
7453.
14. Marano G, Vaglio S, Pupella S, et al. Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements. Blood Transfus 2015;13(2):184-196.
15. Juhl D, Hennig H. Parvovirus B19: What Is the Relevance in Transfusion Medicine?. Front Med (Lausanne) 2018;5:4.
16. Obeid KM. Infections with DNA Viruses, Adenovirus, Polyomaviruses, and Parvovirus B19 in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignan-
cies. Infect Dis Clin North Am 2019;33(2):501-521.
17. Riipinen A, Sallmén M, Hedman L, et al. Increased risk of human parvovirus B19 infection in day-care employees: a cohort study among pregnant workers during an epidemic in Finland. Oc-
cup Environ Med 2014;71(12):836-841.
18. Brown KE. Parvovirus B19 and Bocaviruses. In: Jorgensen JH, Pfaller MA, eds. Manual of Clinical Microbiology. 11th edition. Washington, DC: ASM Press; 2015.
19. Pasquinelli G, Bonvicini F, Foroni L, Salfi N, Gallinella G. Placental endothelial cells can be productively infected by Parvovirus B19. J Clin Virol 2009;44(1):33-38.
20. Isa A, Lundqvist A, Lindblom A, Tolfvenstam T, Broliden K. Cytokine responses in acute and persistent human parvovirus B19 infection. Clin Exp Immunol 2007;147(3):419-425.
21. von Kietzell K, Pozzuto T, Heilbronn R, Grössl T, Fechner H, Weger S. Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement
factor C1q. J Virol 2014;88(14):8102-8115.
22. Söderlund-Venermo M, Hokynar K, Nieminen J, Rautakorpi H, Hedman K. Persistence of human parvovirus B19 in human tissues. Pathol Biol (Paris) 2002;50(5):307-316.
23. Kantola K, Hedman L, Tanner L, et al. B-Cell Responses to Human Bocaviruses 1-4: New Insights from a Childhood Follow-Up Study. PLoS One 2015;10(9):e0139096.
24. Bonvicini F, Bua G, Gallinella G. Parvovirus B19 infection in pregnancy-awareness and opportunities. Curr Opin Virol 2017;27:8-14.
25. Attwood LO, Holmes NE, Hui L. Identification and management of congenital parvovirus B19 infection. Prenat Diagn 2020;40(13):1722-1731.
26. Tong LX, Worswick SD. Viral infections in acute graft-versus-host disease: a review of diagnostic and therapeutic approaches. J Am Acad Dermatol 2015;72(4):696-702.
27. Razonable RR. Rare, unusual, and less common virus infections after organ transplantation. Curr Opin Organ Transplant 2011;16(6):580-587.
28. Söderlund-Venermo M, Lahtinen A, Jartti T, et al. Clinical assessment and improved diagnosis of bocavirus-induced wheezing in children, Finland. Emerg Infect Dis 2009;15(9):1423-1430.
29. Christensen A, Nordbø SA, Krokstad S, Rognlien AG, Døllner H. Human bocavirus in children: mono-detection, high viral load and viraemia are associated with respiratory tract infection. J
Clin Virol 2010;49(3):158-162.
30. Kaikkonen L, Söderlund-Venermo M, Brunstein J, et al. Diagnosis of human parvovirus B19 infections by detection of epitope-type-specific VP2 IgG. J Med Virol 2001;64(3):360-365.
31. Us AD. Temel İmmünoloji ve Seroloji. Ankara: Hipokrat Kitabevi; 2016.
32. Thomas HI, Barrett E, Hesketh LM, Wynne A, Morgan-Capner P. Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection. J Clin
Virol 1999;14(2):107-118.
33. Johnson AH, Gough A. False positive parvovirus serology. J Rheumatol 2004;31(3):625-626.
34. Dijkmans AC, de Jong EP, Dijkmans BA, et al. Parvovirus B19 in pregnancy: prenatal diagnosis and management of fetal complications. Curr Opin Obstet Gynecol 2012;24(2):95-101.
35. Eid AJ, Ardura MI; AST Infectious Diseases Community of Practice. Human parvovirus B19 in solid organ transplantation: Guidelines from the American society of transplantation infectious
diseases community of practice. Clin Transplant 2019;33(9):e13535.
36. Dijkman R, Koekkoek SM, Molenkamp R, Schildgen O, van der Hoek L. Human bocavirus can be cultured in differentiated human airway epithelial cells. J Virol 2009;83(15):7739-7748.
37. Vafaie J, Schwartz RA. Parvovirus B19 infections. Int J Dermatol 2004;43(10):747-749.
38. Broliden K, Tolfvenstam T, Norbeck O. Clinical aspects of parvovirus B19 infection. J Intern Med 2006;260(4):285-304.
39. Manaresi E, Gallinella G. Advances in the Development of Antiviral Strategies against Parvovirus B19. Viruses 2019;11(7):659.
40. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004;350(6):586-597.